A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
Public ClinicalTrials.gov record NCT06801223. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, Phase 1b Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sulbactam-Durlobactam in Hospitalized Pediatric Patients From Birth to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Acinetobacter Baumannii-calcoaceticus Complex Infection
Study identification
- NCT ID
- NCT06801223
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Innoviva Specialty Therapeutics
- Industry
- Enrollment
- 48 participants
Conditions and interventions
Interventions
- Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours) Drug
- Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours) Drug
- Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) Drug
- Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours) Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Day to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2026
- Primary completion
- May 4, 2028
- Completion
- May 19, 2028
- Last update posted
- Mar 2, 2026
2026 – 2028
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Medical Center | Los Angeles | California | 90095 | Recruiting |
| Rady Children's Hospital | San Diego | California | 92123 | Recruiting |
| ECU Brody School of Medicine | Greenville | North Carolina | 27834 | Recruiting |
| University of Texas Medical Branch at Galveston | Galveston | Texas | 77555-5302 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06801223, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06801223 live on ClinicalTrials.gov.